Skip to main content
Clinical Trials/ITMCTR2200005602
ITMCTR2200005602
Not yet recruiting
Phase 1

Prospective Cohort Study on the Preventive Effect of Chinese Medicine Prescription of Close Contact Crowd with Winter Influenza

Dongzhimen Hospital of Beijing University of Chinese Medicine0 sitesTBD
ConditionsInfluenza

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Influenza
Sponsor
Dongzhimen Hospital of Beijing University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Prevention
Sex
All

Investigators

Sponsor
Dongzhimen Hospital of Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\) Age 18\-75 years old;
  • 2\) The case collection period is from November to March of the following year. During this trial period, patients who were clinically diagnosed with influenza in the emergency department outpatient department or respiratory department outpatient department, their family members, roommates and other close contacts living together;
  • 3\) Voluntarily participate in the trial and sign the informed consent.

Exclusion Criteria

  • 1\) Patients who have developed flu\-like symptoms, or patients who require/undergo antibiotics and antiviral drug treatment interventions;
  • 2\) Those who have been injected with influenza vaccine or take other Chinese medicines and Chinese patent medicines to prevent influenza;
  • 3\) Pregnant or lactating women;
  • 4\) Patients with severe heart, liver, renal insufficiency or other serious diseases;
  • 5\) Those who are known to be allergic to traditional Chinese medicine ingredients.

Outcomes

Primary Outcomes

Not specified

Similar Trials